Sep 22, 2022 Barry H. Ostrowsky Receives Lifetime Partners in Progress Award

Newark Beth Israel Medical Center Hosts 17th Annual Partners in Progress Awards Celebration

Newark Beth Israel Medical Center Hosts 17th Annual Partners in Progress Awards Celebration

Caption (L to R): Steve Adubato, Ph.D., event MC; Darrell K. Terry, Sr., MHA, MPH, FACHE, FHELA, President and Chief Executive Officer, Newark Beth Israel Medical Center and Children’s Hospital of New Jersey; Francis J. Giantomasi, Esq., Board Chair, Newark Beth Israel Medical Center and Children’s Hospital of New Jersey; Mark E. Manigan, President, RWJBarnabas Health; Atiya Jaha-Rashidi, MHA, RN, Chief Equity Officer and Vice President of Community Relations, Newark Beth Israel Medical Center and Children’s Hospital of New Jersey; Marc E. Berson, Chair Emeritus, Newark Beth Israel Medical Center and Children’s Hospital of New Jersey, and RWJBarnabas Health Board member; Barry H. Ostrowsky, Chief Executive Officer, RWJBarnabas Health and Lifetime Partner in Progress Awardee; and Lester J. Owens, Board Chair, RWJBarnabas Health

NEWARK, NJ (Sept. 22, 2022) – Barry H. Ostrowsky, Chief Executive Officer, RWJBarnabas Health, received the Lifetime Partner in Progress award at Newark Beth Israel Medical Center’s 17th annual Celebrating Newark: Partners in Progress event on September 13th. Mr. Ostrowsky will be retiring from his role on December 31, 2022, after more than 30 years of leadership within the enterprise. Mark E. Manigan, current President of RWJBarnabas Health, will assume the role of President and Chief Executive Officer of the system on January 1, 2023.

“We are forever grateful to Barry for his visionary leadership and unwavering support of Newark Beth Israel Medical Center. His innovative approach to health care, the social determinants of health, and ending racism, have transformed the way we support the communities we serve, and laid a solid foundation for our future,” said Darrell K. Terry, Sr., MHA, MPH, FACHE, FHELA, President and Chief Executive Officer, Newark Beth Israel Medical Center and Children’s Hospital of New Jersey.

Partners in Progress honors the individuals and institutions who have demonstrated a steadfast commitment to the Newark renaissance. Proceeds from this year’s event will benefit Newark Beth Israel Medical Center’s Newark Strong projects, a $150 million expansion of the facility that includes a 17,000-square-foot, glass-enclosed main lobby, expanded adult and pediatric emergency departments, new hybrid operating rooms, new critical care units, and a new geriatric unit.

To support Partners in Progress or learn how you can support Newark Beth Israel Medical Center, visit newarkbethgiving.org

Newark Beth Israel Medical Center, an RWJBarnabas Health facility, is a 665-bed regional care teaching hospital that provides comprehensive health care. Newark Beth Israel is a Top Teaching Hospital and home to one of the nation’s top 15 heart transplant centers, which has performed more than 1,100 heart transplants. NBI has been designated a World’s Best Hospital-USA by Newsweek and has six consecutive “A” grades for safety from The Leapfrog Group. The hospital has earned the Joint Commission’s Gold Seal of Approval for acute coronary syndrome, congestive heart failure and ventricular assist device and is nationally accredited by the Commission on Cancer. Newark Beth Israel is home to RWJBarnabas Health’s Heart Failure Treatment and Transplant Program; New Jersey’s only Advanced Lung Disease and Transplant Program and a Valve Center that performs complex cardiac valve procedures, including minimally invasive transcatheter aortic valve replacements (TAVRs). Newark Beth Israel Medical Center is also home to Children’s Hospital of New Jersey (CHoNJ), which cares for children from birth through adolescence, with more than 30 specialized pediatric services including New Jersey’s largest Valerie Fund Children’s Center for Cancer and Blood Disorders; and the Children’s Heart Center that offers a complete range of medical and surgical treatments for the most complex cardiac abnormalities. The Newark Beth Israel robotic surgery program is the most experienced in northern New Jersey. RWJBarnabas Health and The Frederick B. Cohen, MD, Comprehensive Cancer and Blood Disorders Center at Newark Beth Israel Medical Center and the Healthcare Foundation of New Jersey Breast Health Center, in partnership with Rutgers Cancer Institute of New Jersey – the state's only NCI-designated Comprehensive Cancer Center – brings a world class team of researchers and specialists to fight alongside you, providing close-to-home access to the latest treatment and clinical trials. Newark Beth Israel also offers many preventive health programs that promote wellness in the community, including The Beth Greenhouse, which provides access to fresh produce and health and wellness education to local residents.

Media Contact:
Linda Kamateh
973-926-7531
linda.kamateh@rwjbh.org